Bharat Biotech’s Covaxin’s phase three data shows 65.2% efficacy against Delta variant…
The findings in the medical journal also revealed that the Indian-made vaccine showed 70.8% efficacy against all coronavirus variants…
Recover your password.
A password will be e-mailed to you.